Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Centessa Pharmaceuticals (CNTA) Treasury Shares (2022 - 2025)

Centessa Pharmaceuticals (CNTA) has disclosed Treasury Shares for 4 consecutive years, with $1.0 million as the latest value for Q3 2025.

  • Quarterly Treasury Shares rose 637.18% to $1.0 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $1.0 million through Sep 2025, up 637.18% year-over-year, with the annual reading at $1.5 million for FY2024, 387.04% up from the prior year.
  • Treasury Shares for Q3 2025 was $1.0 million at Centessa Pharmaceuticals, down from $1.1 million in the prior quarter.
  • The five-year high for Treasury Shares was $2.4 million in Q1 2024, with the low at $34746.0 in Q1 2025.
  • Average Treasury Shares over 4 years is $1.1 million, with a median of $947168.0 recorded in 2022.
  • Peak annual rise in Treasury Shares hit 637.18% in 2025, while the deepest fall reached 98.58% in 2025.
  • Over 4 years, Treasury Shares stood at $599421.0 in 2022, then plummeted by 48.27% to $310052.0 in 2023, then surged by 387.04% to $1.5 million in 2024, then tumbled by 31.43% to $1.0 million in 2025.
  • According to Business Quant data, Treasury Shares over the past three periods came in at $1.0 million, $1.1 million, and $34746.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.